August 10, 2016
Sawai President Mitsuo Sawai Japanese generic major Sawai Pharmaceutical is stepping up its drive to branch out overseas, now aiming to seek first-to-file (FTF) status in the US to earn 180-day generic market exclusivity there for five products now being...read more